Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,735	2,489	1,792	1,936	698	346
Market Cap Growth	38.90%	38.90%	-7.42%	177.28%	101.66%	-10.41%
Enterprise Value	2,221	2,050	1,675	1,684	528	219
Last Close Price	22.52	20.87	16.81	18.60	6.77	3.34
PE Ratio	17.19	15.19	25.10	23.30	17.68	4.62
Forward PE	15.80	15.38	14.13	14.98	13.97	8.97
PS Ratio	5.43	5.06	4.50	9.04	4.96	2.91
PB Ratio	3.74	3.42	4.62	6.44	3.38	2.04
P/TBV Ratio	4.79	4.36	9.25	7.22	3.38	2.04
P/FCF Ratio	11.43	10.40	-	18.26	11.76	7.69
P/OCF Ratio	11.41	10.38	12.48	16.68	11.56	7.69
EV/Sales Ratio	4.52	4.17	4.21	7.86	3.75	1.84
EV/EBITDA Ratio	9.53	8.80	13.99	16.33	10.03	5.30
EV/EBIT Ratio	11.38	10.51	19.29	16.53	10.07	5.31
EV/FCF Ratio	9.28	8.57	-	15.88	8.89	4.87
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.02	0
Debt / EBITDA Ratio	0.01	0.01	0.03	0.04	0.08	0.00
Debt / FCF Ratio	0.01	0.01	-	0.04	0.07	0.00
Asset Turnover	0.74	0.74	0.94	0.70	0.66	0.78
Inventory Turnover	4.01	4.01	4.76	4.92	6.20	10.15
Quick Ratio	4.83	4.83	2.52	5.37	7.32	6.45
Current Ratio	5.17	5.17	2.88	5.57	7.76	7.00
Return on Equity (ROE)	29.38%	29.38%	20.75%	32.76%	20.98%	58.30%
Return on Assets (ROA)	18.46%	18.46%	12.83%	20.75%	15.22%	16.94%
Return on Capital (ROIC)	21.73%	21.73%	15.60%	24.70%	17.20%	19.99%
Return on Capital Employed (ROCE)	26.70%	26.70%	22.00%	32.00%	24.90%	24.40%
Earnings Yield	599.22%	6.58%	3.98%	4.29%	5.66%	21.66%
FCF Yield	874.76%	9.61%	-3.06%	5.48%	8.50%	13.00%
Buyback Yield / Dilution	-983.70%	-9.84%	-2.14%	-3.32%	-1.46%	-0.21%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q